Peter Virsik

All filings by Peter Virsik on record concern ESSA Pharma Inc. The record holds 14 filings, for trades running from 5 January 2024 to 7 October 2024.

No open-market purchase appears, only 11 sales worth €762k. The rest of the record consists of 3 option exercises.

The latest filing, published on 7 October 2024, reports an open-market sale of €3,813 in ESSA Pharma Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.